Tweet SAN JOSE, CA, Outset Medical today announced a $125 million Series E equity financing round led by D1 Capital Partners.

To export Outset Medical funding data to PDF and Excel, clickClick here for more funding data on Outset MedicalTo export Outset Medical funding data to PDF and Excel, click here Outset Medical, a leading medtech innovator delivering first-of-its-kind technology into the growing global dialysis market, today announced a $125 million Series E equity financing round led by D1 Capital Partners.

Designed to reduce the cost and complexity of dialysis, Tablo expands how, when, and where dialysis can be provided.

Cooley LLP acted as legal advisor for Outset Medical in connection with the financing.

About D1 Capital PartnersD1 Capital LP is a global investment advisory firm that operates across public and private markets. | To read full story, visit https://startuparound.com/read/1580866206.8707874/Outset-Medical-Receives-$125M-Series-E?ref=audio_experience